Last updated on February 2019

PF-06804103 Dose Escalation in HER2 Positive Solid Tumors


Brief description of study

The study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of PF-06804103 in patients with HER2 positive solid tumors. The study will expand to look at the selected dose in patients with breast cancer, gastric cancer and non-small cell lung cancer

Clinical Study Identifier: NCT03284723

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

The University of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »

Pfizer CT.gov Call Center

UCLA Hematology/Oncology
Los Angeles, CA United States
  Connect »

Pfizer CT.gov Call Center

Santa Monica - UCLA Medical Center and Orthopaedic Hospital
Santa Monica, CA United States
  Connect »

Pfizer CT.gov Call Center

UCLA Dept of Medicine - Hematology/Oncology, Santa Monica
Santa Monica, CA United States
  Connect »

Pfizer CT.gov Call Center

UCLA Hematology/Oncology - Santa Monica
Santa Monica, CA United States
  Connect »

Pfizer CT.gov Call Center

University of Utah, Huntsman Cancer Institute
Salt Lake City, UT United States
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario Fundaci n Jim nez D az
Madrid, Spain
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario HM Sanchinarro
Madrid, Spain
  Connect »

Pfizer CT.gov Call Center

Banner- University Medical Center Tucson Campus LLC
Tucson, AZ United States
  Connect »

Pfizer CT.gov Call Center

The University of Arizona Cancer Center - North Campus
Tucson, AZ United States
  Connect »

Pfizer CT.gov Call Center

Banner-University Medical Center Tucson
Tucson, AZ United States
  Connect »

Pfizer CT.gov Call Center

(IRB#17-001086) Ronald Reagan UCLA Medical Center, Drug Information Center
Los Angeles, CA United States
  Connect »

Pfizer CT.gov Call Center

Severance Hospital, Yonsei University Health System
Seoul, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

Seoul National University Hospital
Seoul, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

Samsung Medical Center
Seoul, Korea, Republic of
  Connect »

Pfizer CT.gov Call Center

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA United States
  Connect »

Pfizer CT.gov Call Center

University of Utah, Huntsman Cancer Hospital
Salt Lake City, UT United States
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario Vall d'Hebron
Barcelona, Spain
  Connect »

Pfizer CT.gov Call Center

Cedars-Sinai Medical Center
Los Angeles, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.